• SENSEX
    NIFTY 50
Healthcare

Don't expect Ranitidine to return in the market for next 2 years, says Strides Pharma

Updated : May 21, 2020 03:43 PM IST

R Ananthanarayanan, MD and CEO of Strides Pharma tells CNBC-TV18 that they have stopped selling Ranitidine across all markets even before USFDA's request came in.

You May Also Like

Live TV
Advertisement